Kevin Dolowy Dalgaard Email and Phone Number
Kevin Dolowy Dalgaard work email
- Valid
- Valid
Kevin Dolowy Dalgaard personal email
- Valid
Kevin Dolowy Dalgaard is a Principal | Lundbeckfonden BioCapital | Venture Capital | Business Development | Life Sciences | PhD | at Lundbeckfonden / Lundbeck Foundation. He possess expertise in molecular biology, cell culture, biochemistry, pcr, western blotting and 29 more skills. He is proficient in English. Colleagues describe him as "Kevin is a friendly, hard-working and meticulous person who is also an excellent multi-tasker. I know him for the last four and a half years as someone who has strong time management skills and a built-in tendency to always help his peers. I am glad that I met Kevin during my time here in Germany and I wish him all the very best for his future endeavors.", "I first met Kevin in 2010, when he entered the International Max-Planck PhD Research School in the laboratory of A. Pospisilik, where I was PostDoc. I immediately felt what came true soon after: Kevin is an extremely motivated guy, devoted to work and always opened to innovation. Kevin developed technical and scientific independence and is now 100% able to independently plan and manage research projects. He is the perfect team player. Great friend and omnipresent colleague, I would love to have him as a member of my group and, therefore, I highly recommend him for any position he might apply.", and "Kevin was a true student of life science, and excelled by thinking in new ways. Always full of humor and a vivid personal character."
Lundbeckfonden / Lundbeck Foundation
View-
PrincipalLundbeckfonden / Lundbeck Foundation Jun 2022 - PresentCopenhagen, Capital Region, DkLundbeckfonden BioCapital is an evergreen venture capital fund that invests in life science companies, supporting the translation and commercialization of ground-breaking science. -
Board Observer, Board Of DirectorsNotify Therapeutics Sep 2023 - PresentCopenhagen, DkNotify Therapeutics focuses on the initial ovarian follicle development, in the hormone-independent phase, to help infertile women that do not benefit from today’s standard hormone treatment. -
Board Observer, Board Of DirectorsVarmx Aug 2022 - PresentLeiden, NlVarmX is a drug development company, developing drugs to restore haemostasis in case of bleeding or emergency surgery in patients taking oral factor Xa inhibitors. -
Board Observer, Board Of DirectorsAfyx Therapeutics Aug 2022 - Dec 2023Hørsholm, DkAFYX Therapeutics is a topical drug delivery company developing a pipeline of targeted treatments for conditions that currently lack approved therapy options.AFYX acquired by Inphena in January 2024. -
Associate Director, Sp Business Development & Licensing Cardiometabolism And Retinal HealthBoehringer Ingelheim Mar 2020 - May 2022Ingelheim Am Rhein, Rhineland-Palatinate, De• Leading global licensing activities for CardioMetabolism and Retinal Health, ranging from search and evaluation of opportunities, internal approval to enabling business negotiations and deal execution• Development and implementation of licensing and partnering strategy based on the overall TA strategies -
Portfolio Manager / Global Portfolio Lead / Senior Research ScientistNovo Nordisk Oct 2017 - Mar 2020Bagsværd, Dk• Portfolio manager for new anti-diabetics: Driving innovation, external sourcing, stakeholder management, and preparation of reports and presenting for upper management.• Involved in due diligences, initiation of strategic partnerships, in-licensing deals and research collaborations.• Commercial assessment of early projects including preparation of Target Product Profiles (TPPs), strategic fit and commercial attractiveness assessments and valuations.• Planning and driving pre-clinical research projects within Type 2 Diabetes. -
Research ScientistNovo Nordisk Jun 2015 - Oct 2017Bagsværd, DkGLP-1 & T2D Pharmacology• Project management of pre-clinical research with focus on T2DM. • In vivo pharmacology: Setting objectives, execution and realization ofresearch plans to support anti-diabetes portfolio. -
Postdoctoral Researcher - Diabetes & ObesityMax-Planck Institute Of Immunobiology And Epigenetics Sep 2014 - May 2015Freiburg Im Breisgau, Baden-Württemberg, DeEpigenetic Control of Metabolic DiseasesLab: Dr. J. Andrew PospisilikObjective: Understand how environmental cues influence metabolic diseases (diabetes, obesity).• Planning, organising and designing rodent experiments.• In vivo metabolic phenotyping (indirect calorimetry, telemetry, OGTT, ITT).• Pharmacological and dietary interventions.• NGS-sequencing (ChIP-seq, RNA-seq, MeDIP-seq, WGBS/RRBS-seq).• NGS data analysis (R, Tophat, Bowtie, Cufflinks, DESeq, Bismark, MACS). -
Phd RepresentativeMax-Planck Institute Of Immunobiology And Epigenetics Jan 2011 - Feb 2014Freiburg Im Breisgau, Baden-Württemberg, DeAs a PhD representative I represented the other PhD students by effectively communicating between them and administrators. Furthermore, I organised several social events, PhD meetings and actively participated in the screening and selection of new PhD candidates for the IMPRS doctoral programme. -
Research InternshipUniversity Of Cambridge Nov 2013 - Dec 2013Cambridge, England, GbAs a part of a collaboration, I worked in the lab of Prof. Anne Ferguson-Smith to get hands-on experience with quantitative bisulfite pyrosequencing for quantitative assessment of DNA methylation levels of imprinting control regions. -
Research InternshipUniversity Of Stavanger Jun 2009 - Jul 2009Stavanger, Rogaland, NoBiochemical characterization of recombinantly expressed proteins involved in DNA repair using "hot"-reagents. Lab: Professor Svein Bjelland. -
Teaching AssistantUniversity Of Copenhagen Mar 2007 - Jul 2007København K, DkSupervision of undergraduate students.
Kevin Dolowy Dalgaard Skills
Kevin Dolowy Dalgaard Education Details
-
The Max Planck Institute Of Immunobiology And EpigeneticsMolecular Biology -
Københavns Universitet - University Of CopenhagenBiochemistry -
Københavns Universitet - University Of CopenhagenBiochemistry
Frequently Asked Questions about Kevin Dolowy Dalgaard
What company does Kevin Dolowy Dalgaard work for?
Kevin Dolowy Dalgaard works for Lundbeckfonden / Lundbeck Foundation
What is Kevin Dolowy Dalgaard's role at the current company?
Kevin Dolowy Dalgaard's current role is Principal | Lundbeckfonden BioCapital | Venture Capital | Business Development | Life Sciences | PhD |.
What is Kevin Dolowy Dalgaard's email address?
Kevin Dolowy Dalgaard's email address is ke****@****ail.com
What schools did Kevin Dolowy Dalgaard attend?
Kevin Dolowy Dalgaard attended The Max Planck Institute Of Immunobiology And Epigenetics, Københavns Universitet - University Of Copenhagen, Københavns Universitet - University Of Copenhagen.
What skills is Kevin Dolowy Dalgaard known for?
Kevin Dolowy Dalgaard has skills like Molecular Biology, Cell Culture, Biochemistry, Pcr, Western Blotting, Protein Chemistry, Lifesciences, Cell Biology, Biotechnology, Protein Purification, Cell, Qpcr.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial